• LAST PRICE
    2.2400
  • TODAY'S CHANGE (%)
    Trending Down-0.0800 (-3.4483%)
  • Bid / Lots
    2.2300/ 16
  • Ask / Lots
    2.2400/ 16
  • Open / Previous Close
    2.3200 / 2.3200
  • Day Range
    Low 2.2201
    High 2.3400
  • 52 Week Range
    Low 1.8650
    High 38.2000
  • Volume
    449,724
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 2.32
TimeVolumeVTYX
09:32 ET36052.32
09:36 ET31802.32
09:38 ET47792.3136
09:39 ET27272.32
09:41 ET8002.32
09:43 ET8042.33
09:45 ET22212.32
09:48 ET10042.299
09:50 ET11502.31
09:54 ET5792.31
09:57 ET36652.29
09:59 ET3082.29
10:01 ET1002.295
10:03 ET25902.315
10:06 ET8562.3
10:08 ET5302.29
10:10 ET18592.28
10:12 ET6632.28
10:14 ET17722.29
10:15 ET5002.2943
10:17 ET2002.3
10:21 ET3002.3
10:24 ET20352.3
10:28 ET39972.2908
10:30 ET9002.3
10:32 ET26562.29
10:33 ET83802.29
10:35 ET137262.305
10:37 ET22122.295
10:39 ET25822.29
10:42 ET10502.295
10:44 ET2002.29
10:46 ET1002.295
10:48 ET8002.29
10:50 ET271812.285
10:51 ET28912.285
10:53 ET3792.29
10:55 ET8002.28
10:57 ET46572.28
11:00 ET13262.275
11:02 ET22002.2708
11:04 ET1002.275
11:06 ET42482.27
11:08 ET36812.275
11:09 ET2002.27
11:11 ET42142.28
11:13 ET4002.285
11:15 ET30392.275
11:18 ET43732.28
11:20 ET41062.28
11:22 ET2002.2792
11:24 ET25342.275
11:26 ET1002.275
11:27 ET1002.27
11:29 ET26882.27
11:31 ET20202.265
11:33 ET4582.2619
11:36 ET13002.265
11:38 ET123252.265
11:40 ET55722.265
11:42 ET3002.265
11:44 ET8312.265
11:45 ET4002.26
11:47 ET13222.26
11:49 ET24322.2592
11:51 ET2002.26
11:54 ET2992.2592
11:56 ET10272.26
11:58 ET36862.265
12:00 ET4002.265
12:02 ET16592.265
12:03 ET2392.2599
12:05 ET14032.26
12:07 ET4002.265
12:09 ET50782.265
12:12 ET6002.265
12:14 ET66762.265
12:16 ET7002.265
12:18 ET34962.265
12:20 ET17622.266
12:21 ET62382.265
12:23 ET8002.265
12:25 ET4002.265
12:27 ET5002.265
12:30 ET135462.26
12:32 ET69082.27
12:34 ET4002.265
12:36 ET106612.265
12:38 ET29912.275
12:39 ET26042.27
12:41 ET5462.2692
12:43 ET4002.265
12:45 ET4002.265
12:48 ET9002.27
12:50 ET1002.27
12:52 ET36082.26
12:54 ET98782.265
12:56 ET31602.27
12:57 ET39002.28
12:59 ET6182.285
01:01 ET27772.285
01:03 ET15152.285
01:06 ET52222.275
01:08 ET17752.265
01:10 ET1002.265
01:12 ET37002.265
01:14 ET91202.265
01:15 ET43202.26
01:17 ET46322.265
01:19 ET11502.265
01:21 ET18282.26
01:24 ET3002.26
01:26 ET6002.26
01:28 ET2002.25
01:30 ET5002.26
01:33 ET5182.258
01:35 ET35002.26
01:37 ET8772.255
01:39 ET9652.26
01:42 ET2002.26
01:44 ET79072.255
01:46 ET2002.255
01:48 ET17002.255
01:50 ET104702.245
01:51 ET22002.245
01:53 ET40412.2592
01:55 ET13582.265
01:57 ET28982.26
02:00 ET16402.2507
02:02 ET20602.265
02:04 ET3002.265
02:06 ET2002.265
02:08 ET13782.265
02:09 ET4002.265
02:11 ET86962.265
02:13 ET4002.26
02:15 ET9002.265
02:18 ET11172.265
02:20 ET2002.265
02:22 ET37762.2623
02:24 ET4002.2601
02:26 ET3002.2616
02:27 ET157582.25
02:29 ET6002.245
02:31 ET6702.2408
02:33 ET54482.255
02:36 ET10002.255
02:38 ET5002.25
02:40 ET32072.25
02:42 ET1002.25
02:44 ET44332.235
02:45 ET18012.2201
02:47 ET55132.2315
02:49 ET7002.2301
02:51 ET7842.232
02:54 ET9002.24
02:56 ET1002.24
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVTYX
Ventyx Biosciences Inc
162.1M
-0.7x
---
United StatesINMB
INmune Bio Inc
163.4M
-4.1x
---
United StatesCNTX
Context Therapeutics Inc
159.7M
-1.6x
---
United StatesVIGL
Vigil Neuroscience Inc
165.0M
-1.9x
---
United StatesCRVS
Corvus Pharmaceuticals Inc
165.1M
-5.4x
---
United StatesCMPX
Compass Therapeutics Inc.
156.9M
-2.8x
---
As of 2024-08-01

Company Information

Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet need. The Company’s pipeline includes VTX002 (S1P1R Modulator), VTX958 (TYK2 Inhibitor), and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). VTX002 is a sphingosine 1 phosphate receptor (S1P1R) modulator in Phase II development for patients with moderately to severely active ulcerative colitis (UC). VTX958 is an oral, selective clinical-stage inhibitor of tyrosine kinase type 2 (TYK2), an intracellular signaling kinase in the Janus kinase (JAK) family that regulates chronic inflammation in immune-mediated diseases. Its third product candidate, VTX2735, is a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor. In addition to VTX2735, it is also developing VTX3232, its lead CNS-penetrant NLRP3 inhibitor in Phase 1 development.

Contact Information

Headquarters
12790 El Camino Real, Suite 200SAN DIEGO, CA, United States 92130
Phone
858-945-2393
Fax
302-655-5049

Executives

Executive Chairperson of the Board
Sheila Gujrathi
President, Chief Executive Officer, Founder, Director
Raju Mohan
Chief Financial Officer
Martin Auster
Chief Operating Officer
Matthew Moore
Chief Scientific Officer
John Nuss

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$162.1M
Revenue (TTM)
$0.00
Shares Outstanding
70.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-3.24
Book Value
$4.12
P/E Ratio
-0.7x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.